93 related articles for article (PubMed ID: 12905739)
1. [Therapeutic effect of recombinant human parathyroid hormone(1-34) on osteoporosis of ovariectomized rats].
Wang HF; Jin WF; Gao JJ; Gu SZ; Zhou Y; Sun AL; Hu F; Shen J; Zhang SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):275-9. PubMed ID: 12905739
[TBL] [Abstract][Full Text] [Related]
2. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
3. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis.
Zanchetta JR; Bogado CE; Ferretti JL; Wang O; Wilson MG; Sato M; Gaich GA; Dalsky GP; Myers SL
J Bone Miner Res; 2003 Mar; 18(3):539-43. PubMed ID: 12619939
[TBL] [Abstract][Full Text] [Related]
4. Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of ovariectomized rats.
Zhang KQ; Chen JW; Li QN; Li GF; Tian XY; Huang LF; Bao LH; Wang ML
Acta Pharmacol Sin; 2002 Jul; 23(7):659-62. PubMed ID: 12100763
[TBL] [Abstract][Full Text] [Related]
5. The teriparatide in the treatment of severe senile osteoporosis.
Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
[TBL] [Abstract][Full Text] [Related]
7. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
8. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
10. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.
Brommage R; Hotchkiss CE; Lees CJ; Stancill MW; Hock JM; Jerome CP
J Clin Endocrinol Metab; 1999 Oct; 84(10):3757-63. PubMed ID: 10523026
[TBL] [Abstract][Full Text] [Related]
11. The effect of clomiphene citrate on osteoporosis in ovariectomized rats.
Uyar Y; Koltan SO; Pögün S; Vatansever S; Caglar H
Arch Gynecol Obstet; 2008 Aug; 278(2):107-14. PubMed ID: 18193254
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
[TBL] [Abstract][Full Text] [Related]
13. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
Ebeling PR; Russell RG
Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
[TBL] [Abstract][Full Text] [Related]
14. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
15. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
16. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months.
Paschalis EP; Burr DB; Mendelsohn R; Hock JM; Boskey AL
J Bone Miner Res; 2003 Apr; 18(4):769-75. PubMed ID: 12674338
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model.
Das AS; Mukherjee M; Mitra C
Asia Pac J Clin Nutr; 2004; 13(2):210-6. PubMed ID: 15228990
[TBL] [Abstract][Full Text] [Related]
19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.
Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K
Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
